
Sign up to save your podcasts
Or


Host JC Scott speaks with Dan Judy, Analyst and Polling Expert at North Star Opinion Research, about his recent polls finding that benefits managers are overwhelmingly satisfied with results on Pharmacy Benefit Managers (PBMs). Despite these positive results, JC and Dan discuss why PBMs still suffer from a “trust deficit” in the public eye.
High Satisfaction with PBMs: Overall, North Star’s polling results found that the vast majority of employers/benefit managers are satisfied with PBMs. Most benefits managers also agreed that their contracts with PBM are transparent and that PBM tools and programs (such as mail orders) are helpful to their employees.
Stabilizing Drug Costs: More than half of North Star’s surveyed benefits managers reported that drug costs remained stable over the past year. JC notes that stabilized drug prices improve consumer experiences and point to increased satisfaction with PBMSs.
Overcoming the Trust Deficit: Despite these positive polling results, JC and Dan discuss why there remains a perception that PBMs are non-transparent and increase drug costs. They offer that the combination of charged political discourse on drug pricing and “blame-shifting” within the healthcare industry have fostered continued public skepticism toward PBMs.
You can subscribe to The Pharmacy Benefit on Spotify, Google Podcasts, Apple Podcasts, and all other major platforms.
JC Scott speaks with Doug Long, Vice President of Industry Relations at IQVIA, about the impact of COVID-19 on the pharmaceutical market. Long discusses the data trends for pharmaceutical companies during COVID-19 and, most importantly, how these trends impact healthcare patients.
Prescription Stockpiling: With news of the impending pandemic, patients around the US began to stockpile 90-day prescriptions in March. As a consequence, the pharmaceutical marketplace experienced a major decrease in demand in the following two months. Long describes the effects of this “prescription rush” and subsequent demand decrease on the pharmaceutical industry.
Access Prescriptions and Shortages: JC and Long discuss methods by which patients are receiving their prescriptions during COVID-19. Mail-order and other socially distant methods (such as deliveries) have grown in popularity. Long also details how the pharmaceutical industry has responded to recent supply chain shortages. Overall, he is impressed by the resilience of the pharmaceutical supply chain (which includes manufacturing, PBMs, pharmacies, wholesalers, and logistics companies) during COVID-19.
Growth of TeleHealth: Long touches on the impact of telehealth on the healthcare marketplace and medical prescriptions. He notes the dramatic growth of telehealth in a matter of just a few months, and he believes that telehealth is here to stay. However, he cautions that telehealth may have a negative impact on prescription trends for patients.
You can subscribe to The Pharmacy Benefit on Spotify, Google Podcasts, Apple Podcasts, and all other major platforms.
Host JC Scott speaks with Mostafa Kamal, CEO of Magellan Rx Management, about the evolving role of the PBM market in delivering solutions to its clients. JC and Mostafa also discuss challenges to Medicaid during the current economic downfall, as well as upcoming technological innovations to improve the patient experience.
PBM Tools Drive Affordability and Care for Medicaid: Recent unemployment hikes are expected to put severe strains on Medicaid. States across the US will have budgetary pressures to cope with the surge of new patients. Magellan Rx Management is delivering solutions to US States and DC to lower costs and improve efficiency for their Medicaid programs.
New PBM Market Disruptors Are Emerging: Innovators (i.e., “disruptors”) identify and eliminate market inefficiencies to improve customer experiences. In the age of COVID-19 and changing consumer expectations, Mostafa anticipates an increase in the pace of PBM market disruptions. JC and Mostafa discuss some major disruptions on the horizon, including drone home deliveries, real-time information sharing, and predictive modeling to identify medication non-adherence risks.
Greater Personalized Care in the Future: Mostafa believes that future PBM market disruptors will focus on the personalization of medicine. He foresees a customized, genetic-based pharmacy experience for each patient.
You can subscribe to The Pharmacy Benefit on Spotify, Google Podcasts, Apple Podcasts, and all other major platforms.
Host JC Scott speaks with Tim Wentworth, the president of Cigna Express Scripts and Cigna Services, about how Cigna--along with the entire pharmaceutical industry--are addressing the COVID-19 pandemic. Wentworth is optimistic that the ingenuity of the US healthcare system can combat COVID-19 and that current industry-wide collaborations can survive beyond the current pandemic. Some key points from the conversation include:
Cigna Continues to Put the Patient First During COVID-19: Since the start of the outbreak in March, Cigna has focused on the safety of its employees, customers, and most of all, patients. Wentworth emphasizes that Cigna is dynamically managing the supply chain and acting flexibly and nimbly to ensure pharmaceutical access to the clients. It is also working with federal and state officials to ensure a balanced pharmaceutical policy.
The Pharmaceutical Industry is Collaborating To Address the Current Health Crisis: Wentworth is optimistic about the cooperation between industry members to ensure the patients continue to receive care. For example, Cigna is now collaborating with retail pharmacies to put in place a new program with deep discounts for uninsured patients. The entire industry is working to ensure that those suffering from healthcare and economic fallouts from COVID-19 are not forgotten. He believes that such collaboration can continue in the future.
US Health Sector Innovation Is the Best Bet Against COVID-19: US biotechnology and pharmaceutical companies are working in an unprecedented manner to find solutions to COVID-19. Wentworth believes that Cigna, and the entire industry, will find a way to ensure access to COVID-19 for its patients. He stresses that it is a public health decision more than it is a commercial decision.
You can subscribe to The Pharmacy Benefit on Spotify, Google Podcasts, Apple Podcasts, and all other major platforms.
Host JC Scott speaks with Mark Newsom, the principal and founder at Health Evaluations LLC, on the core role of Pharmacy Benefit Managers (PBMs). Newsom goes through the process PBMs take to get us, the consumers, the most effective medications for the lowest premiums. He also discusses PBMs and their role in conjunction with the other players in the industry. Some key points from the conversation include:
Why PBMs Exist And How Savings Are Generated For The Consumers: Newsom accentuates how PBMs’ role in doing the formulary is one of the biggest steps in reducing costs of prescriptions while also increasing the safety of the consumer. He also focuses on how negotiations between manufacturers and pharmacies is a key area for lowering prices. These savings from each individual step help consumers save 40-50% on their annual costs in the form of lower premiums.
A Breakdown Of Where The Money Flows And The Thin Line Of Profit PBMs Tread On: JC Scott breaks down the purchasing dollar and where it goes within the pharmaceutical industry and questions Newsom about the low profit margins of PBMs. Newsom explains how much money is saved for every dollar spent on PBMs, and how even a low percentage of the total money involving pharmaceutical drugs goes a long way when there are billions of prescriptions every year.
What Actions Undermine The Work Of PBMs: Newsom discusses how everyone wanting everything hurts the effectiveness of PBMs working to get people quality prescriptions at lower costs. With individual preferences and politics getting involved, PBMs must work around these obstacles in order to provide the best service they can.
You can subscribe to The Pharmacy Benefit on Spotify, Google Podcasts, Apple Podcasts, and all other major platforms.
Welcome to The Pharmacy Benefit! Hosted by JC Scott, President and CEO of the Pharmaceutical Care Management Association, The Pharmacy Benefit talks about the latest trends, public policy developments, and political challenges impacting drug pricing and healthcare.
You'll hear the nation's top thought leaders, policy experts, and political analysts on a wide variety of topics from insulin affordability to advancements in gene therapy, biologics, other cutting edge therapies.
The Pharmacy Benefit will also analyze the latest news from inside the industry and give you an educated perspective on where things stand and where they're headed.
Subscribe today on Apple Podcasts, Google Podcasts, Spotify or wherever you get your podcasts.